The postdoctoral position is for 2 years and the general research topic will be focused on the biological evaluation (in vitro and especially in vivo experiments) of new polymer-based nanocarriers for the administration of anticancer drugs.
Planned february 2022
The post-doc position is opened for a minimum of 1 year for a project aiming at incorporating nucleic acids in extracellular vesicles for delivery to the central nervous system.
The postdoc will be part of the ANR project HyDNano working closely with different partners from industry and academic research groups. The aim of the project is to optimize and characterize novel nanomedicines for the oral delivery of genetic material for autoimmune disease.